Rilexine Palatable 300 mg - 259 Tabs
Virbac |
RIXPL1D300

Rilexine Palatable 300 mg - 259 Tabs

Prescription Product

This is a Schedule 4 (S4) Controlled Substance. Supply is strictly regulated under Australian law. Valid authorisation is required to purchase this product.

Enquire today to create an account

Register
Description
For the treatment of bacterial infections susceptible to cephalexin:
  • Infections of soft cutaneous tissues.
  • Respiratory and digestive infections.
  • Urinary infections.
  • Prevention and treatment of osteomyelitis.


KEY CHARACTERISTICS
  • Broad-spectrum and bactericidal.
  • Activity against a wide range of Gram-positive and Gram-negative bacteria.
  • Simple dosing.
  • Palatable tablets for dogs and cats.

BENEFITS
  • Rilexine is a broad-spectrum cephalosporin antibiotic with bactericidal activity against a wide range of Grampositive and Gram-negative bacteria.
  • Excellent tissue diffusion and persistence. Rilexine binds very poorly to plasma proteins (< 15%) allowing it to diffuse rapidly into the tissues, where it concentrates at the site of infection.
  • Cephalexin is a good antibiotic choice for infections in skin and bone.
  • Palatable tablets improve owner compliance.


PRESENTATION:
300 mg x 259 tablets
Additional Information
[Zebravet_Files]:
[Zebravet_Files]
Classification:
S4
Categorisation:
Prescription